Effect of Luspatercept on Red Blood Cell (RBC) Transfusion Burden, Iron Chelation Therapy (ICT), and Iron Overload in Adults with Transfusion-Dependent β-Thalassemia (TDT) from the BELIEVE Trial: A Long-Term Analysis
Year: 2022
Type: article
Source: Blood
Institutions: Hôpital Necker-Enfants Malades, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Institut des Maladies Génétiques Imagine, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, American University of Beirut Medical Center, University of Southern California, Children's Hospital Los Angeles, Mahidol University, National and Kapodistrian University of Athens, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), University College London
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310114314